Veterinary oncology market profiled in new Brakke Consulting reportSeptember 15, 2017Brakke Consulting in Dallas has announced the release of a new study that profiles the veterinary oncology sector. "Oncology is one of the highest interest areas in veterinary medicine today," said Lynn Fondon DVM, a senior consultant at Brakke Consulting. "In the past decade, the U.S. has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development." The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented. It estimates the current sales of veterinary-approved cancer therapies, as well as provides estimates of the total number of pets treated with chemotherapy or immunotherapy. "We surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer," said Dr. Fondon. The report, …
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
